TANG CAPITAL MANAGEMENT LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$552.7B
Holdings
20
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 15,238,782 | $204.7B | 37.03% | |
| 2 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $67.8B | 12.27% | |
| 3 | HRTXHERON THERAPEUTICS INC | 2,896,904 | $42.9B | 7.77% | |
| 4 | —BIOHAVEN PHARMACTL HLDG CO L | 599,091 | $38.9B | 7.05% | |
| 5 | ANABANAPTYSBIO INC | 2,628,678 | $38.8B | 7.02% | |
| 6 | —LA JOLLA PHARMACEUTICAL CO | 9,405,490 | $37.9B | 6.86% | |
| 7 | BUWABIO RAD LABS INC | 40,000 | $20.6B | 3.73% | |
| 8 | RLMDRELMADA THERAPEUTICS INC | 500,000 | $18.8B | 3.40% | |
| 9 | UTHUNITED THERAPEUTICS CORP DEL | 160,000 | $16.2B | 2.92% | |
| 10 | GBYSANGAMO THERAPEUTICS INC | 1,578,795 | $14.9B | 2.70% | |
| 11 | PBYIPUMA BIOTECHNOLOGY INC | 1,246,121 | $12.6B | 2.27% | |
| 12 | CHRSCOHERUS BIOSCIENCES INC | 550,000 | $10.1B | 1.83% | |
| 13 | —AVROBIO INC | 700,000 | $9.1B | 1.65% | |
| 14 | —LIFESCI ACQUISITION CORP | 500,000 | $6.8B | 1.23% | |
| 15 | —BCTG ACQUISITION CORP | 468,750 | $4.9B | 0.88% | |
| 16 | EGRXEAGLE PHARMACEUTICALS INC | 62,262 | $2.6B | 0.48% | |
| 17 | VNDAVANDA PHARMACEUTICALS INC | 191,426 | $1.8B | 0.33% | |
| 18 | PRTAPROTHENA CORP PLC | 178,688 | $1.8B | 0.32% | |
| 19 | CTMXCYTOMX THERAPEUTICS INC | 112,880 | $751.0M | 0.14% | |
| 20 | TENXTENAX THERAPEUTICS INC | 460,000 | $708.0M | 0.13% |